HomepageCZMWF • OTCMKTS
add
Carl Zeiss Meditec
Vorige slotkoers
$Â 61,22
Jaar-range
$Â 61,21 - $Â 133,53
Beurswaarde
5,11Â mld. EUR
Gem. volume
78,00
Koers/winst
-
Dividendrendement
-
Primaire beurs
ETR
Marktnieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
| (EUR) | jun 2024info | Wijziging j-o-j |
|---|---|---|
Opbrengst | 539,34Â mln. | 0,79% |
Bedrijfskosten | 238,78Â mln. | 11,27% |
Netto inkomsten | 34,13Â mln. | -62,96% |
Netto winstmarge | 6,33 | -63,24% |
Winst per aandeel | 0,43 | — |
EBITDA | 60,11Â mln. | -43,58% |
Effectief belastingtarief | 32,31% | — |
Balans
Totale activa
Totale passiva
| (EUR) | jun 2024info | Wijziging j-o-j |
|---|---|---|
Contanten en kortetermijnbeleggingen | 15,34Â mln. | 24,06% |
Totale activa | — | — |
Totale passiva | — | — |
Totaal aandelenvermogen | 2,11 mld. | — |
Uitstaande aandelen | 89,74 mln. | — |
Koers-boekwaardeverhouding | 2,62 | — |
Rendement op activa | — | — |
Rendement op kapitaal | 6,08% | — |
Kasstroom
Nettomutatie in liquide middelen
| (EUR) | jun 2024info | Wijziging j-o-j |
|---|---|---|
Netto inkomsten | 34,13Â mln. | -62,96% |
Operationele kasstroom | — | — |
Kasstroom uit beleggingen | — | — |
Kasstroom uit financiering | — | — |
Nettomutatie in liquide middelen | — | — |
Vrije kasstroom | — | — |
Over
Carl Zeiss Meditec AG is a multinational medical technology company and subsidiary of Carl Zeiss AG. It manufactures tools for eye examinations and medical lasers as well as solutions for neurosurgery, dentistry, gynecology and oncology. Among its products are the most common tools used by ophthalmologists and optometrists.
In October 2018, Carl Zeiss Meditec won FDA premarket approval for its ReLEx Smile laser system.
Also in October 2018, Carl Zeiss Meditec announced the acquisition of Reno, Nevada-based IanTech for an undisclosed sum.
In September 2019, Carl Zeiss Meditec launched the CIRRUS 6000 at the European Society of Retina Specialists 2019 Congress. Wikipedia
CEO
Opgericht
2002
Hoofdvestiging
Werknemers
4.950
